内脏脂肪在胃癌应用中的研究进展
Research Progress in the Application of Visceral Fat in Gastric Cancer
DOI: 10.12677/ACM.2023.13122895, PDF,   
作者: 崔桂芳, 缪 巍*:青海大学附属医院胃肠肿瘤外科,青海 西宁
关键词: 内脏脂肪胃癌内脏型肥胖Visceral Fat Gastric Cancer Visceral Obesity
摘要: 目前肥胖率在全球范围内呈快速增长趋势,已成为一个重要的公共卫生问题。流行病学资料表明内脏型肥胖可增加多种疾病包括胃癌的发生风险。深入了解内脏脂肪与胃癌间的相关性,将为内脏脂肪型胃癌的防治提供新思路。本文就内脏脂肪与胃癌发病、治疗及预后的相关性,以及其相关机制研究进展作一综述。
Abstract: At present, the obesity rate is showing a rapid growth trend globally and has become an important public health issue. Epidemiological data shows that visceral obesity can increase the risk of various diseases, including gastric cancer. A deep understanding of the correlation between visceral fat and gastric cancer will provide new ideas for the prevention and treatment of visceral fat type gastric cancer. This article reviews the correlation between visceral fat and the pathogenesis, treatment, and prognosis of gastric cancer, as well as the research progress on its related mechanisms.
文章引用:崔桂芳, 缪巍. 内脏脂肪在胃癌应用中的研究进展[J]. 临床医学进展, 2023, 13(12): 20585-20594. https://doi.org/10.12677/ACM.2023.13122895

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021) Global Cancer Sta-tistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] WHO (2020) Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019.
[3] 中国居民营养与慢性病状况报告(2020年) [J]. 营养学报, 2020, 42(6): 521.
[4] Pan, X.F., Wang, L. and Pan, A. (2021) Epidemiology and De-terminants of Obesity in China. The Lancet Diabetes & Endocrinology, 9, 373-392. [Google Scholar] [CrossRef
[5] 郭美云. 肥胖与消化系统肿瘤发病风险的研究进展[J]. 医疗装备, 2022, 35(16): 191-194.
[6] 郭雄文, 李树峰. 肥胖与胃癌关系的研究现状及展望[J]. 中国普外基础与临床杂志, 2017, 24(6): 779-783.
[7] Cho, D.H., Kim, M.N., Joo, H.J., et al. (2019) Visceral Obesity, but Not Central Obesity, Is Associated with Cardiac Remodeling in Subjects with Suspected Metabolic Syndrome. Nutrition, Metabolism and Cardiovascular Diseases, 29, 360-366. [Google Scholar] [CrossRef] [PubMed]
[8] Tabuso, M., Homer-Vanniasinkam, S., Adya, R. and Arasaradnam, R.P. (2017) Role of Tissue Microenvironment Resident Adipo-cytes in Colon Cancer. World Journal of Gastroenterology, 23, 5829-5835. [Google Scholar] [CrossRef] [PubMed]
[9] Singh, D. (1993) Adaptive Significance of Female Physical Attrac-tiveness: Role of Waist-to-Hip Ratio. Journal of Personality and Social Psychology, 65, 293-307. [Google Scholar] [CrossRef
[10] Avgerinos, K.I., Spyrou, N., Mantzoros, C.S., et al. (2019) Obe-sity and Cancer Risk: Emerging Biological Mechanisms and Perspectives. Metabolism, 92, 121-135. [Google Scholar] [CrossRef] [PubMed]
[11] Ozoya, O.O., Siegel, E.M., Srikumar, T., et al. (2017) Quantita-tive Assessment of Visceral Obesity and Postoperative Colon Cancer Outcomes. Journal of Gastrointestinal Surgery, 21, 534-542. [Google Scholar] [CrossRef] [PubMed]
[12] Takeuchi, M., Ishii, K., Seki, H., et al. (2016) Excessive Visceral Fat Area as a Risk Factor for Early Postoperative Complications of Total Gastrectomy for Gastric Cancer: A Retrospective Cohort Study. BMC Surgery, 16, Article No. 54. [Google Scholar] [CrossRef] [PubMed]
[13] Liesenfeld, D.B., Grapov, D., Fahrmann, J.F., Salou, M., Scherer, D., Toth, R., Habermann, N., Böhm, J., et al. (2015) Metabolomics and Transcriptomics Identify Pathway Differences between Visceral and Subcutaneous Adipose Tissue in Colorectal Cancer Patients: The ColoCare Study. The American Journal of Clinical Nutrition, 102, 433-443. [Google Scholar] [CrossRef] [PubMed]
[14] Yu, H., Joh, Y.G., Son, G.M., et al. (2016) Distribution and Impact of the Visceral Fat Area in Patients with Colorectal Cancer. Annals of Coloproctology, 32, 20-26. [Google Scholar] [CrossRef] [PubMed]
[15] Sakamaki, K., Maejima, Y., Tokita, Y., et al. (2016) Impact of the Visceral Fat Area Measured by Dual Impedance Method on the Diagnostic Components of Metabolic Diseases in a Mid-dle-Aged Japanese Population. Internal Medicine, 55, 1691-1696. [Google Scholar] [CrossRef] [PubMed]
[16] Finch, P. (2017) Intra-Abdominal Fat: Comparison of Com-puted Tomography Fat Segmentation and Bioimpedance Spectroscopy. Malawi Medical Journal, 29, 155-159. [Google Scholar] [CrossRef] [PubMed]
[17] 徐艺文, 朱惠娟. 内脏脂肪的测定及临床应用进展[J]. 医学综述, 2016, 22(13): 2575-2578.
[18] Marra, M., Sammarco, R., De Lorenzo, A., et al. (2019) Assessment of Body Composi-tion in Health and Disease Using Bioelectrical Impedance Analysis (BIA) and Dual Energy X-Ray Absorptiometry (DXA): A Critical Overview. Contrast Media & Molecular Imaging, 2019, Article ID: 3548284. [Google Scholar] [CrossRef] [PubMed]
[19] Ward, L.C. (2019) Bioelectrical Impedance Analysis for Body Compo-sition Assessment: Reflections on Accuracy, Clinical Utility, and Standardisation. European Journal of Clinical Nutrition, 73, 194-199. [Google Scholar] [CrossRef] [PubMed]
[20] Gao, B., Liu, Y., Ding, C., et al. (2020) Comparison of Visceral Fat Area Measured by CT and Bioelectrical Impedance Analysis in Chinese Patients with Gastric Cancer: A Cross-Sectional Study. BMJ Open, 10, e036335. [Google Scholar] [CrossRef] [PubMed]
[21] Eto, K., Ida, S., Ohashi, T., et al. (2020) Perirenal Fat Thick-ness as a Predictor of Postoperative Complications after Laparoscopic Distal Gastrectomy for Gastric Cancer. BJS Open, 4, 865-872. [Google Scholar] [CrossRef] [PubMed]
[22] Okamura, T., Hashimoto, Y., Hamaguchi, M., et al. (2020) Visceral Adiposity Index Is a Predictor of Incident Colorectal Cancer: A Population-Based Longitudinal Study. BMJ Open Gastroenterology, 7, e000400. [Google Scholar] [CrossRef] [PubMed]
[23] Xia, M.F., Chen, Y., Lin, H.D., et al. (2016) A Indicator of Visceral Adipose Dysfunction to Evaluate Metabolic Health in Adult Chinese. Scientific Reports, 6, Article No. 38214. [Google Scholar] [CrossRef] [PubMed]
[24] 徐怿琳, 魏晨敏, 桑苗苗, 等. 中国中老年人群内脏脂肪指数与胰岛素抵抗和糖代谢的关系[J]. 南京医科大学学报(自然科学版), 2018, 38(9): 1252-1258.
[25] Han, M., Qie, R., Li, Q., Liu, L., Huang, S., Wu, X., Zhang, D., et al. (2021) Chinese Visceral Adiposity Index, a Novel Indicator of Visceral Obesity for Assessing the Risk of Incident Hypertension in a Prospective Cohort Study. British Journal of Nutrition, 126, 612-620. [Google Scholar] [CrossRef
[26] Wang, Y., Zhao, X., Chen, Y., Yao, Y., Zhang, Y., Wang, N., Liu, T. and Fu, C. (2022) Visceral Adiposity Measures Are Strongly Associated with Cardiovascular Disease among Female Participants in Southwest China: A Population-Based Prospective Study. Frontiers in Endocrinology (Lausanne), 13, Article ID: 969753. [Google Scholar] [CrossRef] [PubMed]
[27] Tang, M., Wei, X.H., Cao, H., Zhen, Q., Liu, F., Wang, Y.F., Fan, N.G. and Peng, Y.D. (2022) Association between Chinese Visceral Adiposity Index and Metabolic-Associated Fatty Liver Disease in Chinese Adults with Type 2 Diabetes Mellitus. Frontiers in Endocrinology (Lausanne), 13, Article ID: 935980. [Google Scholar] [CrossRef] [PubMed]
[28] Zhao, Y., Zhang, J., Chen, C., Qin, P., Zhang, M., Shi, X., Yang, Y., Lu, J., Sun, L. and Hu, D. (2022) Comparison of Six Surrogate Insulin Resistance Indexes for Predicting the Risk of Incident Stroke: The Rural Chinese Cohort Study. Diabetes/Metabolism Research and Reviews, 38, e3567. [Google Scholar] [CrossRef] [PubMed]
[29] Machann, J., Stefan, N., Wagner, R., et al. (2020) Normalized Indices De-rived from Visceral Adipose Mass Assessed by Magnetic Resonance Imaging and Their Correlation with Markers for Insulin Resistance and Prediabetes. Nutrients, 12, Article No. 2064. [Google Scholar] [CrossRef] [PubMed]
[30] 周玉洁, 兰宁, 赵怡宁, 等. 内脏脂肪指数对胃癌患者根治术后补充性肠外营养期间血糖与短期并发症的影响[J]. 兰州大学学报(医学版), 2023, 49(1): 32-40+47. [Google Scholar] [CrossRef
[31] Matsui, R., Inaki, N. and Tsuji, T. (2022) Impact of Visceral Adipose Tissue on Long-Term Outcomes after Gastrectomy for Advanced Gastric Cancer. Nutrition, 97, Article ID: 111619. [Google Scholar] [CrossRef] [PubMed]
[32] Harada, K., Baba, Y., Ishimoto, T., et al. (2015) Low Visceral Fat Content Is Associated with Poor Prognosis in a Database of 507 Upper Gastrointestinal Cancers. Annals of Surgical Oncology, 22, 3946-3953. [Google Scholar] [CrossRef] [PubMed]
[33] Silveira, E.A., Kliemann, N., Noll, M., et al. (2021) Visceral Obe-sity and Incident Cancer and Cardiovascular Disease: An Integrative Review of the Epidemiological Evidence. Obesity Reviews, 22, e13088. [Google Scholar] [CrossRef] [PubMed]
[34] Sung, H., Siegel, R.L., Torre, L.A., et al. (2019) Global Patterns in Excess Body Weight and the Associated Cancer Burden. CA: A Cancer Journal for Clinicians, 69, 88-112. [Google Scholar] [CrossRef] [PubMed]
[35] Lauby-Secretan, B., Scoccianti, C., Loomis, D., et al. (2016) Body Fatness and Cancer-Viewpoint of the IARC Working Group. The New England Journal of Medicine, 375, 794-798. [Google Scholar] [CrossRef
[36] Friedenreich, C.M., Ryder-Burbidge, C. and McNeil, J. (2021) Physical Activity, Obesity and Sedentary Behavior in Cancer Etiology: Epidemiologic Evidence and Biologic Mecha-nisms. Molecular Oncology, 15, 790-800. [Google Scholar] [CrossRef] [PubMed]
[37] Li, H.J., Che, X.M., Zhao, W., He, S.C., Zhang, Z.L., Chen, R., Fan, L. and Jia, Z.L. (2013) Diet-Induced Obesity Promotes Murine Gastric Cancer Growth through a nampt/sirt1/c-myc Pos-itive Feedback Loop. Oncology Reports, 30, 2153-2160. [Google Scholar] [CrossRef] [PubMed]
[38] Chen, X., Chen, W., Huang, Y., et al. (2019) A Quantified Risk-Scoring System Including the Visceral Fat Area for Peritoneal Metastasis of Gastric Cancer. Cancer Management and Research, 11, 2903-2913. [Google Scholar] [CrossRef
[39] Huang, H., Yang, X., Sun, J., et al. (2020) Value of Visceral Fat Area in the Preoperative Discrimination of Peritoneal Metastasis from Gastric Cancer in Patients with Different Body Mass Index: A Prospective Study. Cancer Management and Research, 12, 6523-6532. [Google Scholar] [CrossRef
[40] Yang, S.J., Li, H.R., Zhang, W.H., et al. (2020) Visceral Fat Area (VFA) Superior to BMI for Predicting Postoperative Complications after Radical Gastrectomy: A Prospective Cohort Study. Journal of Gastrointestinal Surgery, 24, 1298-1306. [Google Scholar] [CrossRef] [PubMed]
[41] Taniguchi, Y., Kurokawa, Y., Takahashi, T., et al. (2021) Im-pacts of Preoperative Psoas Muscle Mass and Visceral Fat Area on Postoperative Short- and Long-Term Outcomes in Patients with Gastric Cancer. World Journal of Surgery, 45, 815-821. [Google Scholar] [CrossRef] [PubMed]
[42] 张萍, 杨学堂, 王莹. 腹内脂肪组织总面积对腹腔镜远端胃癌切除术效果的影响[J]. 中国现代普通外科进展, 2019, 22(4): 328-330.
[43] 吴凯强, 张伟, 杨克硕, 等. CT测量内脏脂肪面积对腹腔镜胃癌切除术后发生并发症的预测价值[J]. 中华实用诊断与治疗杂志, 2022, 36(7): 667-671. [Google Scholar] [CrossRef
[44] 徐艳群, 江涌, 张跃, 等. 内脏脂肪面积对腹腔镜胃癌根治手术效果影响的研究[J]. 中华普外科手术学杂志(电子版), 2016, 10(5): 414-416.
[45] 付广华, 牛兆建, 周岩冰, 等. 内脏脂肪面积对腹腔镜胃癌根治术的影响[J]. 中华胃肠外科杂志, 2015, 18(8): 804-807.
[46] Go, J.E., Kim, M.C., Kim, K.H., et al. (2015) Effect of Visceral Fat Area on Outcomes of Laparoscopy Assisted Distal Gastrectomy for Gastric Cancer: Subgroup Analysis by Gender and Parameters of Obesity. Annals of Surgical Treatment and Research, 88, 318-324. [Google Scholar] [CrossRef] [PubMed]
[47] 王纪全, 蔡梦娇, 龚柳云, 等. 腹部内脏脂肪面积对根治性胃癌切除术后患者预后诊断价值[J]. 西部医学, 2019, 31(9): 1375-1379.
[48] 牛磊, 刘烺飚, 蔡军. 内脏脂肪增多对腹腔镜辅助远端胃癌根治术围手术期的影响[J]. 国际外科学杂志, 2021, 48(9): 599-604.
[49] 王雅权, 闫宇, 董胜利. 内脏脂肪面积作为胃癌患者术后并发症预测指标有效性的Meta分析[J]. 中国现代手术学杂志, 2023, 27(3): 171-179. [Google Scholar] [CrossRef
[50] Okada, K., Nishigori, T., Obama, K., et al. (2019) The Incidence of Postoperative Complications after Gastrectomy Increases in Proportion to the Amount of Preoperative Vis-ceral Fat. Journal of Oncology, 2019, Article ID: 8404383. [Google Scholar] [CrossRef] [PubMed]
[51] Kim, J.H., Kim, J., Lee, W.J., et al. (2019) A High Viscer-al-to-Subcutaneous Fat Ratio Is an Independent Predictor of Surgical Site Infection after Gastrectomy. Journal of Clinical Medicine, 8, Article No. 494. [Google Scholar] [CrossRef] [PubMed]
[52] Inoue, K., Yoshiuchi, S., Yoshida, M., et al. (2019) Preoperative Weight Loss Program Involving a 20-Day Very Low-Calorie Diet for Obesity before Laparoscopic Gastrectomy for Gastric Cancer. Asian Journal of Endoscopic Surgery, 12, 43-50. [Google Scholar] [CrossRef] [PubMed]
[53] Matsunaga, T., Saito, H., Murakami, Y., et al. (2016) Usefulness of T-Shaped Gauze for Precise Dissection of Supra-Pancreatic Lymph Nodes and for Reduced Postoperative Pancreatic Fistula in Patients Undergoing Laparoscopic Gastrectomy for Gastric Cancer. Yonago Acta Medica, 59, 232-236.
[54] Tsujiura, M., Hiki, N., Ohashi, M., et al. (2017) “Pancre-as-Compressionless Gastrectomy”: A Novel Laparoscopic Approach for Suprapancreatic Lymph Node Dissection. An-nals of Surgical Oncology, 24, 3331-3337. [Google Scholar] [CrossRef] [PubMed]
[55] Wada, T., Kunisaki, C., Ono, H.A., Makino, H., Akiyama, H. and Endo, I. (2015) Implications of BMI for the Prognosis of Gastric Cancer among the Japanese Population. Digestive Sur-gery, 32, 480-486. [Google Scholar] [CrossRef] [PubMed]
[56] Ongaro, E., Buoro, V., Cinausero, M., Caccialanza, R., Turri, A., Fanotto, V., et al. (2017) Sarcopenia in Gastric Cancer: When the Loss Costs Too Much. Gastric Cancer, 20, 563-572. [Google Scholar] [CrossRef] [PubMed]
[57] Matsui, R., Inaki, N. and Tsuji, T. (2021) Impact of Visceral Ad-ipose Tissue on Compliance of Adjuvant Chemotherapy and Relapse-Free Survival after Gastrectomy for Gastric Cancer: A Propensity Score Matching Analysis. Clinical Nutrition, 40, 2745-2753. [Google Scholar] [CrossRef] [PubMed]
[58] Zhang, Y., Li, Z., Jiang, L., et al. (2021) Impact of Body Composi-tion on Clinical Outcomes in People with Gastric Cancer Undergoing Radical Gastrectomy after Neoadjuvant Treatment. Nutrition, 85, Article ID: 111135. [Google Scholar] [CrossRef] [PubMed]
[59] Feng, W., Huang, M., Zhao, X., et al. (2020) Severe Loss of Vis-ceral Fat and Skeletal Muscle after Chemotherapy Predicts Poor Prognosis in Metastatic Gastric Cancer Patients without Gastrectomy. Journal of Cancer, 11, 3310-3317. [Google Scholar] [CrossRef] [PubMed]
[60] Park, H.S., Kim, H.S., Beom, S.H., et al. (2018) Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat after Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial. Annals of Surgical Oncology, 25, 3222-3230. [Google Scholar] [CrossRef] [PubMed]
[61] 李啸文, 仇广林, 王海江, 等. 内脏脂肪面积对胃癌根治术患者预后的影响[J]. 西安交通大学学报(医学版), 2022, 43(3): 419-425.
[62] Bloomgarden, Z. (2018) Diabetes and Branched-Chain Amino Acids: What Is the Link? Journal of Diabetes, 10, 350-352. [Google Scholar] [CrossRef] [PubMed]
[63] Ben-Neriah, Y. and Karin, M. (2011) Inflammation Meets Cancer, with NF-κB as the Matchmaker. Nature Immunology, 12, 715-723. [Google Scholar] [CrossRef] [PubMed]
[64] Lin, Y., He, Z., Ye, J., et al. (2020) Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer. OncoTargets and Therapy, 13, 13023-13032. [Google Scholar] [CrossRef
[65] Li, Q., Zhang, J., Zhou, Y., et al. (2012) Obesity and Gastric Cancer. Frontiers in Bioscience, 17, 2383-2390. [Google Scholar] [CrossRef] [PubMed]
[66] Ju, X., Zhang, H., Zhou, Z., Chen, M., et al. (2020) Tumor-Associated Macro-phages Induce PD-L1 Expression in Gastric Cancer Cells through IL-6 and TNF-α Signaling. Experimental Cell Re-search, 396, Article ID: 112315. [Google Scholar] [CrossRef] [PubMed]
[67] Nieman, K.M., Romero, I.L., Van Houten, B., et al. (2013) Adi-pose Tissue and Adipocytes Support Tumorigenesis and Metastasis. Biochimica et Biophysica Acta, 1831, 1533-1541. [Google Scholar] [CrossRef] [PubMed]
[68] Ghasemi, A., Saeidi, J., Azimi-Nejad, M., et al. (2019) Lep-tin-Induced Signaling Pathways in Cancer Cell Migration and Invasion. Cellular Oncology (Dordr), 42, 243-260. [Google Scholar] [CrossRef] [PubMed]
[69] 高福利, 钱建清. 肥胖与胃癌的相关机制及临床研究[J]. 医学综述, 2014, 20(14): 2545-2547.
[70] Mhaidat, N.M., Alzoubi, K.H., Kubas, M.A., et al. (2021) High Levels of Lep-tin and Non-High Molecular Weight-Adiponectin in Patients with Colorectal Cancer: Association with Chemotherapy and Common Genetic Polymorphisms. Biomedical Reports, 14, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
[71] Muppala, S., Konduru, S.K.P., Merchant, N., et al. (2017) Adiponectin: Its Role in Obesity-Associated Colon and Prostate Cancers. Critical Reviews in Oncology/Hematology, 116, 125-133. [Google Scholar] [CrossRef] [PubMed]
[72] Xie, L., Wang, Y., Wang, S., et al. (2011) Adiponectin In-duces Growth Inhibition and Apoptosis in Cervical Cancer HeLa Cells. Biologia, 66, 712-720. [Google Scholar] [CrossRef
[73] Lu, G.W., Wang, Q.J., Xia, M.M., et al. (2014) Elevated Plasma Visfatin Levels Correlate with Poor Prognosis of Gastric Cancer Patients. Peptides, 58, 60-64. [Google Scholar] [CrossRef] [PubMed]
[74] Dalamaga, M., Christodoulatos, G.S. and Mantzoros, C.S. (2018) The Role of Extracellular and Intracellular Nicotinamide Phosphoribosyl-Transferase in Cancer: Diagnostic and Therapeutic Perspectives and Challenges. Metabolism, 82, 72-87. [Google Scholar] [CrossRef] [PubMed]
[75] Wang, Y., Gao, C., Zhang, Y., et al. (2016) Visfatin Stimulates Endometrial Cancer Cell Proliferation via Activation of PI3K/Akt and MAPK/ERK1/2 Signalling Pathways. Gynecologic Oncology, 143, 168-178. [Google Scholar] [CrossRef] [PubMed]
[76] Gholinejad, Z., Kheiripour, N., Nourbakhsh, M., et al. (2017) Extracellular NAMPT/Visfatin Induces Proliferation through ERK1/2 and AKT and Inhibits Apoptosis in Breast Cancer Cells. Peptides, 92, 9-15. [Google Scholar] [CrossRef] [PubMed]
[77] 伍志通, 覃文周, 叶慧芬, 等. 内脏脂肪素在消化道恶性肿瘤中的研究进展[J]. 中国医药科学, 2021, 11(18): 48-52.
[78] Liu, H., Luo, J., Guillory, B., et al. (2020) Ghrelin Ameliorates Tumor-Induced Adipose Tissue Atrophy and Inflammation via Ghrelin Receptor-Dependent and -Independent Pathways. Oncotarget, 11, 3286-3302. [Google Scholar] [CrossRef] [PubMed]
[79] Deng, T., Lyon, C.J., Bergin, S., et al. (2016) Obesity, Inflamma-tion, and Cancer. Annual Review of Pathology, 11, 421-449. [Google Scholar] [CrossRef] [PubMed]
[80] Kalantarhormozi, M., Jouyan, N., Asadipooya, K., et al. (2020) Evaluation of Adipokines, Adiponectin, Visfatin, and Omentin, in Uncomplicated Type I Diabetes Patients be-fore and after Treatment of Diabetic Ketoacidosis. Journal of Endocrinological Investigation, 43, 1723-1727. [Google Scholar] [CrossRef] [PubMed]
[81] Cao, J. and Yee, D. (2021) Disrupting Insulin and IGF Receptor Function in Cancer. International Journal of Molecular Sciences, 22, Article No. 555. [Google Scholar] [CrossRef] [PubMed]
[82] Van Bree, S.H., Cailotto, C., Di Giovangiulio, M., et al. (2013) Sys-temic Inflammation with Enhanced Brain Activation Contributes to More Severe Delay in Postoperative Ileus. Neurogas-troenterology & Motility, 25, e540-e549. [Google Scholar] [CrossRef] [PubMed]
[83] Iida, M., Takeda, S., Nakagami, Y., et al. (2020) The Effect of the Visceral Fat Area on the Predictive Accuracy of C-Reactive Protein for Infectious Complications after Laparoscopy-Assisted Gas-trectomy. Annals of Gastroenterological Surgery, 4, 386-395. [Google Scholar] [CrossRef] [PubMed]